Recap - The first big news ahead of the American Association for Cancer Research’s (AACR) annual conference hit on Friday morning when Bristol-Myers Squibb (BMY) reported that … Continue Reading
Read nowRecap - In biotech investing, rarely do five trading sessions go by without some explosive volatility. This week, it was Merck’s (MRK) acquistion of Cubist Pharmaceuticals (CBST) for $9 billion, and bluebird … Continue Reading
Read nowRecap - The American Society of Hematology’s annual meeting begins this weekend in San Francisco. It’s a big event for the oncology research community, particularly those studying blood cancers, … Continue Reading
Read nowInsights - Actavis (ACT) continued its acquisition spree on Mondau morning with the purchase of Durata Therapeutics (DRTX) in a deal valued at $675 million. The Dublin based … Continue Reading
Read nowRecap - November is approaching, and the AASLD’s Liver Meeting conference the second week of the month, attracting a bevy of investors this year. The liver has become … Continue Reading
Read nowResearch - Investors are skittish again, and healthcare investors more than others. Here’s why. In the Fed’s semi-annual monetary policy report, which accompanied Chairwoman Janet Yellen’s testimony before … Continue Reading
PremiumResearch - The sector-tracking iShares NASDAQ biotechnology ETF (IBB) took out some major levels of resistance in the Thursday trading session, catching the attention of traders in the … Continue Reading
Read now
